Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by FredTheVoiceon Jan 11, 2021 7:39pm
178 Views
Post# 32272724

RE:RE:Theratechnologies Announces US$40 Million Bought-Deal Public

RE:RE:Theratechnologies Announces US$40 Million Bought-Deal PublicLowtohigh; good question; some on this board will have better answers about the price of the deal.

In 2018, the bought deal was the start of a very long dive for the share price..........14$C to........todays 4$C.

The story is different.....today, my guess : this bought deal is the beggining of the UP-ROAD.

Some will say that it was to fast.....that we could have wait for the share price to be at 6$C before raising money.........but the reality I think is that MACKIE AND NATIONAL BANK pushed in the last few days the price from 2,75$C to 4$C because they put the money were they now know that they will MAKE LOTS......

Lets see how management rolls the dice in the next few months.......

Now, we got MACKIE and the NATIONAL BANK that will put some money in the story.

From my point of view.......2021 will be interesting for TH and, we could make lots of money from here.............

GLTA

FTV.
<< Previous
Bullboard Posts
Next >>